JAG Capital Management
JAG Capital Management Large Cap Growth Portfolio
Jun 2026 → Sep 2026
Our archive holds 2 letters from this strategy and positions in 22 companies. Every quote below is copied verbatim from the letter it came from.
2 letters in a year — follow all of JAG Capital Management for every strategy.
Performance
as of Sep 30, 2026 · net of fees · USD · Model Net
- YTD+15.6%index +6.3%
- 1Y+18.1%index +7.5%
- 3Y · /yr+26.7%index +24.3%
- 5Y · /yr+13.0%index +13.7%
- 10Y · /yr+16.3%index +18.2%
- Inception · /yr+11.8%index +11.6%
Index: Russell 1000 Growth
| YTD | 1Y | 3Yper year | 5Yper year | 10Yper year | Since inceptionper year | |
|---|---|---|---|---|---|---|
| JAG Capital Management Large Cap Growth Portfolio | +15.6% | +18.1% | +26.7% | +13.0% | +16.3% | +11.8% |
| Russell 1000 Growth | +6.3% | +7.5% | +24.3% | +13.7% | +18.2% | +11.6% |
Calendar years
- 2025+13.3%index +17.9%
- 2024+34.4%index +33.4%
- 2023+40.2%index +42.7%
- 2022−30.6%index −29.1%
- 2021+14.3%index +28.7%
- 2020+38.0%index +18.4%
- 2019+19.6%index +31.5%
- 2018−1.0%index −4.4%
- 2017+33.5%index +21.8%
- 2016+2.4%index +12.0%
Disclaimer
These figures are copied from the manager’s latest letter, as of Sep 30, 2026. They were extracted automatically, have not been verified by HF Best Ideas and may contain errors. They cover a single share class, in the currency and fee basis stated above; other share classes and your own returns will differ. This is not investment advice, nor an offer to buy or sell any fund. Past performance does not predict future returns.
Read full disclosures →What it bought and sold
We divested our position following significant outperformance as the upside potential is limited due to elevated expectations, in our view.
We divested our position given deteriorating relative strength and mounting macro headwinds, including higher interest rate yields and elevated fuel costs.
We divested our position as relative strength continued to deteriorate after the company missed its quarterly earnings expectations.
We liquidated our position after the company delivered weaker-than- expected forward guidance in their most recent earnings report, which makes us less confident in the short/intermediate term outlook for the shares.
We exited our position as relative strength continued to deteriorate and as the company could face challenges in scaling production given limitations on the supply of scandium.
We divested our position as relative strength continued to deteriorate after the company missed its quarterly earnings expectations.
We are re-establishing the position as US commercial revenue growth continues to accelerate as enterprises adopt the company’s industry-leading AI solutions.
Recent earnings showed growth acceleration across key metrics as Atlassian’s AI offerings are gaining traction.
We believe the stock is well positioned to outperform tied to healthy consumer demand and undemanding valuations.
We divested our position as quarterly earnings missed elevated expectations and as relative strength continued to deteriorate.
We expect Astera Labs to benefit from this strong AI-related demand and new product launches.
We expect the company to continue benefitting from AI infrastructure buildout, with Dell’s AI orders surpassing >$53B in the most recent quarter.
We exited our position as the recent geopolitical events, including the ongoing conflict in Iran could negatively impact TKO’s business either directly (cancellation of future events scheduled to be held in the region) and/or indirectly because of changes in their relationship with strategic partners in the middle east (ex: Saudi PIF).
We exited our position as investors became concerned about rising capital spending/debt issuance as Oracle is again issuing more debt to fund its data center buildout - contrary to our buy thesis.